Healthy Ageing: a Feasibility Study to Evaluate Digitally-enabled Ways to Support Healthy Ageing

NCT ID: NCT07112352

Last Updated: 2025-08-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

PHASE2

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-07-28

Study Completion Date

2026-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this clinical trial is to learn if it is feasibility to conduct a trial of two digitally-enabled interventions that support older adults to adopt healthy behaviours. It will also learn about the safety of this digital intervention. The main questions it aims to answer are

* How acceptable and feasible are the trial, intervention and control groups in assessing outcomes
* What is the estimated effect of the interventions? Researchers will compare Smart devices with a bespoke 'Healthy Habits' application and three healthy habit coaching and data feedback modules, to a group with smart devices and standard off-the-shelf feedback application, to a control group that will receive an education leaflet to adopt healthy behaviours.

Participants will:

* Use sensors and the 'Healthy Habits' application for 3 months followed by standard application for 3 months, or sensors and standard application for 6 months, or control
* Either home visit or in-centre visit once every 3 months for assessments and online health questionnaires
* Complete daily diary of any healthcare use

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Frailty is defined as a clinical state manifesting in a reduced capacity to tolerate physiological stressors. This is associated with increased usage of healthcare, healthcare costs and reduced quality of life. This study aims to assess the feasibility of conducting a definitive trial comparing two digitally-enabled interventions that support older adults to adopt healthy behaviours compared to a control. Feasibility will be broken down into trial, intervention and control feasibility. The secondary objectives are preliminary estimation of effect size from the interventions and observation of any persistence effect.

This is a three-arm parallel group non-blinded randomised feasibility trial which involves community-dwelling older adults who are 65 years old and above who are pre-frail as defined by Fried Frailty. Participants are recruited from the community setting.

Potential participants are invited to complete an eligibility questionnaire and screened for eligibility. If eligible, they are consented to participate in the study for six months. On receipt of their consent form, they are randomised into three groups. The groups are A: smart devices with personalised data feedback and habit coaching, B: smart devices with data feedback and a Control group with standard care. Group A will use Smart devices (smartwatch and sleep mat) with a bespoke 'Healthy Habits' application and four healthy habit coaching and data feedback modules focused on active minutes, steps and sedentary time, viewable on a tablet. These modules were co-designed and chosen with participants during a previous Design and Feasibility study. At the end of three months, the application is uninstalled and participants continue to use their smart devices with data feedback.

Participants randomised to Group B will use smart devices (smartwatch and sleep mat) with standard off-the-shelf data feedback application ("WithingsTM App") providing generalised data feedback from the participant's smartwatch and sleep mat, viewable on a tablet for 6 months. Participants randomised to the control group will receive standard care where they will be signposted to the NHS guidance on Healthy Ageing for older adults for six months. Participants will undertake baseline, three and six months online and in-person health assessments and blood test. Participants in Groups A and B will be for feedback about their experience of the programme.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Frailty Older Adults (65 Years and Older) Digital Health Intervention Feasibility Studies

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control

Standard care using National Health Service (NHS) guidance on Healthy Ageing for older adults for 6 months.

Group Type OTHER

Control

Intervention Type OTHER

Standard care where they will be signposted to National Health Service (NHS) guidance on Healthy Ageing for older adults.

Smart devices with Personalised data feedback and habit coaching

Participants use smart devices (smartwatch and sleep mat) with a bespoke 'Healthy Habits' application with three healthy habit coaching and data feedback modules focused on active minutes, steps and sedentary time, viewable on a tablet for 3 months. The 'Healthy Habits' application is uninstalled after 3 months and participants will be taught how to use standard 'Withings' application to view their data.

Group Type EXPERIMENTAL

Smart devices with Personalised data feedback and habit coaching

Intervention Type COMBINATION_PRODUCT

Smart devices (smartwatch and sleep mat) with a bespoke 'Healthy Habits' application with three healthy habit coaching and data feedback modules, focused on active minutes, steps and sedentary time, viewable on a tablet.

Smart devices with data feedback

Smart devices (smartwatch and sleep mat) with a standard off-the-shelf data feedback application ("WithingsTM App") providing generalised data feedback from the participant's smartwatch and sleep mat, viewable on a tablet for 6 months.

Group Type ACTIVE_COMPARATOR

Smart devices with data feedback

Intervention Type DEVICE

Smart devices (smartwatch and sleep mat) with a standard off-the-shelf data feedback application ("WithingsTM App") providing generalised data feedback from the participant's smartwatch and sleep mat, viewable on a tablet for 6 months.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Smart devices with Personalised data feedback and habit coaching

Smart devices (smartwatch and sleep mat) with a bespoke 'Healthy Habits' application with three healthy habit coaching and data feedback modules, focused on active minutes, steps and sedentary time, viewable on a tablet.

Intervention Type COMBINATION_PRODUCT

Smart devices with data feedback

Smart devices (smartwatch and sleep mat) with a standard off-the-shelf data feedback application ("WithingsTM App") providing generalised data feedback from the participant's smartwatch and sleep mat, viewable on a tablet for 6 months.

Intervention Type DEVICE

Control

Standard care where they will be signposted to National Health Service (NHS) guidance on Healthy Ageing for older adults.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* • Older adults (age ≥65)

* Community-dwelling Adults living at home
* Living within the London boroughs
* Willing to engage in an exercise programme
* On at least one medication
* Pre-frail on Edmonton-AC and/or FRAIL and PRISMA \< 3
* Clinically assessed to have Fried 1-3 (this is completed at baseline assessment)
* Has the capacity to provide informed consent
* Able to speak and understand written English

Exclusion Criteria

* • Adults less than 65 years old

* Living outside the London boroughs
* Living in a nursing home or hospitalised or hospice
* Not taking any medication (indicating robust frailty status)
* Significant cognitive impairment due to concerns that cognitive impairment and its causes presents different barriers to engagement and participation with sensors and intervention
* Individuals with severe limitations in activities of daily living which would prevent active participation in the assessments, interfere with participation in the physical exercise programme
* Being unable to safely engage in the exercise component for other health-related reasons such as Musculoskeletal or neurological disorders that impair gait speed and balance as these are key outcome metrics
* Progressive or severe medical illness e.g. acute myocardial infarction in the last 3 months, unstable angina, severe aortic stenosis, uncontrolled orthostatic hypotension, recent bone fracture in the last 3 months, having a life expectancy of less than 24 months, requiring palliative care within the following two years, three or more hospitalisations in the last year
* Moderate - Severe Depression, Psychiatric disorders which may interfere with their participation in the study
* Being treated for active cancer
* Unstable medical conditions or where clinical optimisation required e.g. uncontrolled diabetes.
* Participating in other clinical studies
* Unable to participate for 6 months in the study (with 28 days allowed to be away from home)
* Unable to speak or understand written English
Minimum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Imperial College London

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Leila Shepherd, MEng, PhD

Role: PRINCIPAL_INVESTIGATOR

Imperial College London

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Helix Centre, Institute of Global Health Innovation, Department of Surgery and Cancer, Imperial College London

London, , United Kingdom

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United Kingdom

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Tricia HC Tay, MBChB, MSc

Role: CONTACT

+44 020 7594 6950

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Leila Shepherd, MEng, PhD

Role: primary

020 7594 6950

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

7596188

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Healthy Lifetime - Phase 2
NCT05920733 RECRUITING NA
Improving Cardiac Secondary Prevention
NCT03269708 ACTIVE_NOT_RECRUITING NA
Senior Health Clinic Study
NCT05634239 UNKNOWN NA